Floatz logo

Allogenic Placenta Derived Mesenchymal Stem Cells

Idiopathic Pulmonary Fibrosis

The Prince Charles HospitalCell therapyPhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
73/ 100

Competitive context

111 Active assets in the Idiopathic Pulmonary Fibrosis cohort.

Asset / SponsorPhaseRating
Pirfenidone
Endeavor Biomedicines, Inc.
Phase 4A
N-Acetyl-L-Cysteine
Endeavor Biomedicines, Inc.
Phase 4BBB
Nintedanib
Mannkind Corporation
Phase 4BBB
Nerandomilast
Boehringer Ingelheim
Phase 3BB
PREDNISONE TABLETS
Fondation Hôpital Saint-Joseph
Phase 3BB

View all 50 →

Same molecule, other indications

Allogenic Placenta Derived Mesenchymal Stem Cells is also rated in:

secondary progressive multiple sclerosisDormant
CC
Indicative ·
47 / 100
View asset →
Mesenchymal Stem CellsDormant
CC
Indicative ·
47 / 100
View asset →
multiple sclerosisDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →